Masimo Shares Outstanding 2007-2018 | MASI

Masimo shares outstanding history from 2007 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Masimo shares outstanding for the quarter ending September 30, 2018 were 0.056B, a 0.13% increase year-over-year.
  • Masimo 2017 shares outstanding were 0.056B, a 5.04% increase from 2016.
  • Masimo 2016 shares outstanding were 0.053B, a 0.95% decline from 2015.
  • Masimo 2015 shares outstanding were 0.054B, a 3.35% decline from 2014.
Masimo Annual Shares Outstanding
(Millions of Shares)
2017 56
2016 53
2015 54
2014 56
2013 57
2012 58
2011 61
2010 61
2009 60
2008 60
2007 81
2006 20
2005 13
Masimo Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 56
Q2 2018 56
Q1 2018 55
Q4 2017 56
Q3 2017 56
Q2 2017 56
Q1 2017 56
Q4 2016 53
Q3 2016 54
Q2 2016 53
Q1 2016 52
Q4 2015 54
Q3 2015 54
Q2 2015 54
Q1 2015 54
Q4 2014 56
Q3 2014 55
Q2 2014 57
Q1 2014 58
Q4 2013 57
Q3 2013 57
Q2 2013 57
Q1 2013 58
Q4 2012 58
Q3 2012 58
Q2 2012 58
Q1 2012 59
Q4 2011 61
Q3 2011 61
Q2 2011 61
Q1 2011 61
Q4 2010 61
Q3 2010 61
Q2 2010 61
Q1 2010 60
Q4 2009 60
Q3 2009 60
Q2 2009 60
Q1 2009 57
Q4 2008 60
Q3 2008 60
Q2 2008 60
Q1 2008 55
Q4 2007 81
Q3 2007 71
Q2 2007 21
Q1 2007 17
Q3 2006 17
Q2 2006 20
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $5.746B $0.798B
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $94.638B 22.05
Intuitive Surgical (ISRG) United States $56.945B 56.03
Edwards Lifesciences (EW) United States $31.075B 33.26
Fresenius Medical Care AG KGaA (FMS) Germany $24.473B 16.57
IDEXX Laboratories (IDXX) United States $16.961B 48.45
ABIOMED (ABMD) United States $14.078B 101.15
DexCom (DXCM) United States $12.334B 0.00
Teleflex (TFX) United States $11.768B 26.71
Hologic (HOLX) United States $10.836B 17.78
Varian Medical Systems (VAR) United States $10.500B 26.01
STERIS (STE) United Kingdom $9.837B 26.10
LivaNova (LIVN) United Kingdom $5.698B 36.58
Globus Medical (GMED) United States $4.956B 31.14
Penumbra (PEN) United States $4.483B 270.69
Integra LifeSciences Holdings (IART) United States $4.474B 21.79
Wright Medical Group (WMGI) Netherlands $3.542B 0.00
Cantel Medical (CMD) United States $3.428B 34.54
Inogen (INGN) United States $2.825B 60.97
Integer Holdings (ITGR) United States $2.671B 22.35
Halyard Health (AVNS) United States $2.230B 20.09
Glaukos (GKOS) United States $1.993B 0.00
OPKO Health (OPK) United States $1.808B 0.00
Tandem Diabetes Care (TNDM) United States $1.799B 0.00
Mazor Robotics (MZOR) Israel $1.532B 0.00
AxoGen (AXGN) United States $1.233B 0.00
Nevro (NVRO) United States $1.183B 0.00
Luminex (LMNX) United States $1.156B 41.84
Pacific Biosciences Of California (PACB) United States $1.135B 0.00
Orthofix (OFIX) United States $1.086B 31.37
Tactile Systems Technology (TCMD) United States $1.068B 169.97
CryoLife (CRY) United States $1.050B 92.07
Natus Medical (BABY) United States $1.021B 21.44
Intersect ENT (XENT) United States $0.939B 0.00
Accelerate Diagnostics (AXDX) United States $0.770B 0.00
AngioDynamics (ANGO) United States $0.765B 26.75
Mesa Laboratories (MLAB) United States $0.761B 45.02
TransEnterix (TRXC) United States $0.648B 0.00
Veracyte (VCYT) United States $0.540B 0.00
Sientra (SIEN) United States $0.530B 0.00
ViewRay (VRAY) United States $0.485B 0.00
SI-BONE INC (SIBN) United States $0.410B 0.00
Accuray (ARAY) United States $0.398B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.394B 0.00
OrthoPediatrics (KIDS) United States $0.338B 0.00
Neuronetics (STIM) United States $0.327B 0.00
Quotient (QTNT) Switzerland $0.321B 0.00
Nuvectra (NVTR) United States $0.313B 0.00
Fluidigm (FLDM) United States $0.297B 0.00
SeaSpine Holdings (SPNE) United States $0.294B 0.00
IRadimed (IRMD) United States $0.282B 73.66
RTI Surgical (RTIX) United States $0.279B 44.00
GenMark Diagnostics (GNMK) United States $0.254B 0.00
CRH Medical (CRHM) Canada $0.238B 41.00
Corindus Vascular Robotics (CVRS) United States $0.226B 0.00
Helius Medical Technologies (HSDT) United States $0.216B 0.00
Pulse Biosciences (PLSE) United States $0.209B 0.00
T2 Biosystems (TTOO) United States $0.193B 0.00
Ekso Bionics Holdings (EKSO) United States $0.132B 0.00
Alphatec Holdings (ATEC) United States $0.127B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.103B 0.00
Ra Medical Systems (RMED) United States $0.103B 0.00
Second Sight Medical Products (EYES) United States $0.100B 0.00
Sensus Healthcare (SRTS) United States $0.094B 0.00
Restoration Robotics (HAIR) United States $0.077B 0.00
Biosig Technologies (BSGM) United States $0.071B 0.00
Apollo Endosurgery (APEN) United States $0.071B 0.00
EDAP TMS (EDAP) France $0.068B 0.00
Viveve Medical (VIVE) United States $0.066B 0.00
Electromed (ELMD) United States $0.050B 24.04
OBALON THERPTCS (OBLN) United States $0.047B 0.00
Xtant Medical Holdings (XTNT) United States $0.042B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.037B 0.00
Vermillion (VRML) United States $0.036B 0.00
Neovasc (NVCN) Canada $0.035B 0.00
ConforMIS (CFMS) United States $0.033B 0.00
PAVmed (PAVM) United States $0.028B 0.00
Lianluo Smart (LLIT) China $0.028B 0.00
Titan Medical (TMDI) Canada $0.027B 0.00
Dynatronics (DYNT) United States $0.024B 0.00
DarioHealth (DRIO) Israel $0.022B 0.00
ENDRA Life Sciences (NDRA) United States $0.021B 0.00
ReWalk Robotics (RWLK) Israel $0.020B 0.00
Nanovibronix (NAOV) United States $0.016B 0.00
Presbia (LENS) Ireland $0.016B 0.00
American Shared Hospital Services (AMS) United States $0.015B 11.65
Bioanalytical Systems (BASI) United States $0.014B 0.00
Microbot Medical (MBOT) United States $0.010B 0.00
Micron Solutions (MICR) United States $0.010B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Sunshine Heart Inc (CHFS) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Atossa Genetics (ATOS) United States $0.006B 0.00
InspireMD (NSPR) Israel $0.005B 0.00
Avinger (AVGR) United States $0.004B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00
Amedica (SINT) United States $0.000B 0.00
EnteroMedics (RSLS) United States $0.000B 0.00